ASPEN Lipid Injectable Emulsion Safety Recommendations, Part 2: Neonate and Pediatric Considerations

Lipid injectable emulsions (ILEs) are complex pharmaceutical formulations intended as a source of energy and fatty acids for parenteral nutrition (PN). Part 1 of this series addressed adult use. Part 2 addresses ILE safety in neonatal and pediatric patients, who often require higher doses compared with adults to support growth, development, and daily metabolic needs. ILE is often administered as a separate infusion owing to compatibility and stability issues and limitations of access. It is associated with PN errors in the administration, prescribing, and transcribing processes and has been associated with adverse effects, including effects from doses exceeding manufacturer recommendations. This paper describes safe use of ILE products for US neonatal and pediatric patients, including indications, prescribing, order review, preparation, administration, and monitoring. December 2021 Business Corporate by Alex Menco | alexmenco.net Music promoted by www.free-stock-music.com Creative Commons Attribution 3.0 Unported License creativecommons.org/licenses/by/3.0/deed.en_US

There are no comments yet.

Please log in to write the first comment.